𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute promyelocytic leukemia in children

✍ Scribed by Chan, Ka Wah ;Steinherz, Peter G. ;Miller, Denis R.


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
737 KB
Volume
9
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Sixteen children (ages 2–17) with acute promyelocytic leukemia (APL) were studied retrospectively. Diagnosis was based on clinical features and morphological criteria of the FAB classification. Bleeding diathesis was the predominant presenting symptom (>85%), associated with laboratory findings of disseminated intravascular coagulation (DIC). Extramedullary manifestations included skin rash in six patients, gum infiltration in two, and meningeal leukemia in two. Induction therapy consisted of cytosine arabinoside and an anthracycline, with or without other agents. Prophylactic heparinization was given to 12 patients. Six patients (37.5%) failed to achieve remission and died, secondary to hemorrhage in three, and secondary to infection in the remaining three patients. The median duration of remission was 14 months, and the median survival for responders was 21 months. One meningeal leukemia preceded bone marrow relapse despite intermittent intrathecal chemotherapy for prophylaxis. Three patients remain in continuous complete remission 3 years after initial diagnosis.

Although childhood APL shares many features of its adult counterpart, the high frequency of extramedullary manifestations and mortality secondary to neutropenia deserves separate attention.


πŸ“œ SIMILAR VOLUMES


Pharmacology of all-trans-retinoic acid
✍ Lanvers, Claudia ;Reinhardt, Dirk ;DΓΌbbers, Angelika ;Wagner-Bohn, Alexandra ;Cr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 1 views

## Abstract ## Background Due to severe side effects in virtually all children treated with a standard dose of 45 mg/m^2^/day all‐__trans__‐retinoic acid (ATRA) for acute promyelocytic leukemia (APL) the AML‐BFM study group reduced the dosage to 25 mg/m^2^/day. For the lack of data on the use of A

All-trans retinoic acid and short-time,
✍ Schmitt, Klaus; Zoubek, Andreas; Schwarz, Rudolf; Tulzer, Gerald; Koller, Elisab πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 2 views

We report on two girls, 3 and 13 years well tolerated, although both children were old, with acute promyelocytic leukemia critically ill. They achieved a complete remis-(APL) who were successfully treated with all-sion confirmed by light microscopy, but trans retinoic acid (ATRA) 45 mg/m\*/day. reve

Extramedullary acute promyelocytic leuke
✍ Peter H. Wiernik; Roberto De Bellis; Pablo Muxi; Janice P. Dutcher πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 436 KB πŸ‘ 2 views

## BACKGROUND. Extramedullary acute promyelocytic leukemia (APL) is rare, and said to be more common after treatment with all-trans retinoic acid (ATRA) than after any other treatment. ## METHODS. The case of a child with extramedullary relapse of APL after initial treatment with ATRA and that

Extramedullary acute promyelocytic leuke
✍ Frederic Maloisel; Jean Emmanuel Kurtz; Francis Oberling πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 2 views